Biogen

IBD 50: Top 5 Medical Stocks Include Celgene, Actavis

IBD 50: Top 5 Medical Stocks Include Celgene, Actavis

Investors Business Daily

Biogen: Will it Miss Earnings Again?

Biogen: Will it Miss Earnings Again?

Yahoo/Zacks

Biogen's MS Pill Roars Out Of Launch Gate

Biogen's MS Pill Roars Out Of Launch Gate

TheStreet.com

This Week in Biotech

This Week in Biotech

Motley Fool

Biogen Hits Primary Endpoints in MS Study

Biogen Hits Primary Endpoints in MS Study

Motley Fool

Biogen prices new MS drug at discount to key competitors

Biogen prices new MS drug at discount to key competitors

Reuters

Biogen Reveals Pricing For New MS Drug Tecfidera

Biogen Reveals Pricing For New MS Drug Tecfidera

Forbes

Is Teva Just Looking Out for Itself

Is Teva Just Looking Out for Itself

Motley Fool

2013 Should Be Interesting for Multiple Sclerosis Drugs

2013 Should Be Interesting for Multiple Sclerosis Drugs

The Motley Fool

Biogen slips as FDA extends review of MS drug

Biogen slips as FDA extends review of MS drug

Yahoo/AP